Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test

NARecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 17, 2024

Primary Completion Date

September 18, 2025

Study Completion Date

December 1, 2025

Conditions
COVID-19COVID
Interventions
DIAGNOSTIC_TEST

Aptitude Medical Systems Metrix COVID Test

The Metrix COVID Test is a real-time reverse transcription loop-mediated isothermal amplification reaction (RT-LAMP) test that has been designed to detect viral RNA from SARS-CoV-2 via electrochemical detection using the Metrix Reader. Detection of SARS-CoV-2 gene targets will produce a positive SARS-CoV-2 result. If no target is detected and the internal control amplifies, the result is negative. If no amplification is detected in any of the channels, an invalid result is displayed.

Trial Locations (3)

35210

RECRUITING

AFC Montclair, Birmingham

35758

RECRUITING

AFC Madison, Madison

70802

RECRUITING

PPU Mid City, Baton Rouge

Sponsors
All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

lead

Aptitude Medical Systems

INDUSTRY